Table 2.
GEE model for antimicrobial prescribing
| Variables | AB** prescribing | Nitrofurantoin | AMP | ||||||
|---|---|---|---|---|---|---|---|---|---|
| OR | 95 % CI | OR | 95 % CI | OR | 95 % CI | ||||
| Weekdays vs. weekend | |||||||||
| Weekdays | Reference | Reference | Reference | ||||||
| Weekends | 1.07 | 1.04 | 1.10 | 1.12 | 1.03 | 1.21 | 1.06 | 1.01 | 1.11 |
| Gender | |||||||||
| Female | Reference | Reference | Reference | ||||||
| Male | 0.86 | 0.83 | 0.88 | 0.20 | 0.18 | 0.22 | 1.12 | 1.08 | 1.16 |
| Age | 1.00 | 0.99 | 1.00 | 1.01 | 1.01 | 1.02 | 0.99 | 0.99 | 0.99 |
| Medical card type | |||||||||
| Private | Reference | Reference | Reference | ||||||
| GMS* | 0.61 | 0.59 | 0.63 | 1.15 | 1.07 | 1.24 | 0.72 | 0.69 | 0.75 |
| Arms | |||||||||
| Control arm | Reference | Reference | Reference | ||||||
| Intervention arm-1 | 0.79 | 0.77 | 0.82 | 1.05 | 0.97 | 1.13 | 0.77 | 0.74 | 0.80 |
| Intervention arm-2 | 0.98 | 0.95 | 1.01 | 0.93 | 0.86 | 1.01 | 0.89 | 0.86 | 0.94 |
| Variables | AMC | Trimethoprim | Quinolone | ||||||
|---|---|---|---|---|---|---|---|---|---|
| OR | 95 % CI | OR | 95 % CI | OR | 95 % CI | ||||
| Weekdays vs. weekend | |||||||||
| Weekdays | Reference | Reference | Reference | ||||||
| Weekends | 0.89 | 0.84 | 0.96 | 1.04 | 0.89 | 1.22 | 1.06 | 0.94 | 1.21 |
| Gender | |||||||||
| Female | Reference | Reference | Reference | ||||||
| Male | 1.20 | 1.13 | 1.27 | 0.37 | 0.31 | 0.44 | 1.82 | 1.64 | 2.02 |
| Age | 1.00 | 0.99 | 1.00 | 1.01 | 1.01 | 1.01 | 1.02 | 1.02 | 1.02 |
| Medical card type | |||||||||
| Private | Reference | Reference | Reference | ||||||
| GMS* | 0.82 | 0.76 | 0.86 | 1.40 | 1.20 | 1.63 | 1.14 | 1.01 | 1.27 |
| Arms | |||||||||
| Control arm | Reference | Reference | Reference | ||||||
| Intervention arm-1 | 0.93 | 0.87 | 0.99 | 1.13 | 0.96 | 1.33 | 0.97 | 0.86 | 1.12 |
| Intervention arm-2 | 0.91 | 0.86 | 0.98 | 1.13 | 0.96 | 1.33 | 1.02 | 0.91 | 1.16 |
| Variables | Cephalosporin | Tetracycline | Macrolide | ||||||
|---|---|---|---|---|---|---|---|---|---|
| OR | 95 % CI | OR | 95 % CI | OR | 95 % CI | ||||
| Weekdays vs. weekend | |||||||||
| Weekdays | Reference | Reference | Reference | ||||||
| Weekends | 0.95 | 0.81 | 1.10 | 1.08 | 0.95 | 1.24 | 0.95 | 0.88 | 1.03 |
| Gender | |||||||||
| Female | Reference | Reference | Reference | ||||||
| Male | 0.83 | 0.73 | 0.96 | 1.05 | 0.93 | 1.18 | 1.16 | 1.09 | 1.24 |
| Age | 1.01 | 1.01 | 1.01 | 0.99 | 0.99 | 0.99 | 1.00 | 1.00 | 1.00 |
| Medical card | |||||||||
| Private | Reference | Reference | Reference | ||||||
| GMS* | 1.04 | 0.91 | 1.18 | 0.73 | 0.65 | 0.82 | 0.82 | 0.77 | 0.88 |
| Arms | |||||||||
| Control arm | Reference | Reference | Reference | ||||||
| Intervention arm-1 | 1.41 | 1.22 | 1.65 | 1.06 | 0.92 | 1.22 | 1.20 | 1.11 | 1.30 |
| Intervention arm-2 | 1.50 | 1.29 | 1.76 | 1.27 | 1.11 | 1.46 | 1.24 | 1.14 | 1.34 |
** AB antimicrobials, * GMS medical card holder patients